middle.news
Lumos Diagnostics Reports Strong Early Reimbursement for FebriDx in US Rollout
9:49am on Monday 18th of May, 2026 AEST
•
Healthcare
Read Story
Lumos Diagnostics Reports Strong Early Reimbursement for FebriDx in US Rollout
9:49am on Monday 18th of May, 2026 AEST
Key Points
Over 90% of FebriDx reimbursement claims paid
Average payments exceed Medicare fee schedule rate
FebriDx now used in 44 WellStreet urgent care clinics
Eight new pilot sites progressing well
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Lumos Diagnostics (ASX:LDX)
OPEN ARTICLE